Shares of STAR SPORTS MED (01609) continued their upward momentum, climbing more than 7% during Monday's trading session and bringing the stock's cumulative gain for the month to over 35%. At the time of writing, the shares were trading 3.25% higher at HK$159, with a turnover of approximately HK$30.52 million.

On the news front, STAR SPORTS MED released its interim results, reporting revenue of approximately RMB 163 million for the first half of the year, marking a 21.6% year-on-year increase. Adjusted net profit reached roughly RMB 48.9 million, up 24.3% from the same period last year, driven primarily by a significant surge in sales of its core products and effective cost control measures.

Notably, the company has accelerated its international market expansion strategy, a move that has substantially enhanced its overseas market penetration and business scale. During the period, revenue generated from overseas markets amounted to approximately RMB 40.7 million, representing a 70.6% increase compared to the same period in 2025. As a result, the proportion of overseas revenue to total income has risen to 24.9%.